Aquestive Therapeutics, Inc. AQST Contract Liabilities, Non-Current
Contract Liabilities, Non-Current at other companies
Other financials
Where this comes from
Reported directly by Aquestive Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.
The official record: Aquestive Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Aquestive Therapeutics, Inc.'s contract liabilities, non-current.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Aquestive Therapeutics, Inc.'s contract liabilities, non-current?
- Aquestive Therapeutics, Inc. (AQST) reported contract liabilities, non-current of $19.12M in Q1 2026.
- How has Aquestive Therapeutics, Inc.'s contract liabilities, non-current changed year-over-year?
- Aquestive Therapeutics, Inc.'s contract liabilities, non-current decreased by 3.2% year-over-year, from $19.74M to $19.12M.
- What is the long-term trend for Aquestive Therapeutics, Inc.'s contract liabilities, non-current?
- Over 5 years (2020 to 2025), Aquestive Therapeutics, Inc.'s contract liabilities, non-current has grown at a 39.8% compound annual growth rate (CAGR), from $3.63M to $19.39M.